mafosfamide has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonfil, RD; Matar, P; Roggero, EA; Rozados, VR; Scharovsky, OG | 1 |
| Beaujean, F; Benhamou, E; Hartmann, O; Lemerle, J; Rubie, H; Valteau-Couanet, D; Vassal, G | 1 |
2 other study(ies) available for mafosfamide and Neoplasm Metastasis
| Article | Year |
|---|---|
Modulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphoma.
Topics: Adoptive Transfer; Animals; Antineoplastic Agents, Alkylating; Cell Movement; Cyclophosphamide; Drug Administration Schedule; Female; Lymphocyte Transfusion; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Rats, Inbred Strains; Spleen; Splenectomy | 1998 |
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Neuroblastoma; Remission Induction; Treatment Outcome | 1997 |